Physician profile
Simon P Patton
NPI 1497042444
$1,491.33
in general payments reported to CMS, 2019-2025
16 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2021: $634 · 2022: $183 · 2023: $249 · 2024: $100 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429 · Gift: $48.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.48 |
| Gift | $48.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $500.42 | 2021-2023 | Desara |
| Medtronic, INC. | $268.32 | 2021 | |
| Axonics, INC. | $192.99 | 2022-2024 | Bulkamid |
| Sumitomo Pharma America, INC. | $139.31 | 2023 | Gemtesa |
| Boston Scientific Corporation | $106.31 | 2025 | Axonics |
| Pfizer INC. | $47.52 | 2019 | |
| Hologic Sales and Service, LLC | $40.43 | 2022 | |
| Astellas Pharma US INC | $28.71 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.64 | 2019 | |
| Urovant Sciences INC | $25.63 | 2022 | |
| Duchesnay USA Incorporated | $24.13 | 2019 | |
| Applied Medical Resources Corporation | $21.88 | 2025 | |
| Allergan, INC. | $18.73 | 2019 | |
| Abbvie INC. | $18.64 | 2019 | |
| Coloplast Corp | $18.51 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.